Abstract:An enzymatic method has been successfully established enabling the generation of partially base-modified RNA (previously named RZA) constructs, in which all G residues were replaced by isomorphic fluorescent thienoguanosine ( th G) analogs, as well as fully modified RZA featuring th G, 5-bromocytosine, 7-deazaadenine and 5-chlorouracil. The transcriptional efficiency of emissive fully modified RZA was found to benefit from the use of various T7 RNA polymerase variants. Moreover, d th G could be incorporated into PCR products by Taq DNA polymerase together with the other three base-modified nucleotides. Notably, the obtained RNA products containing th G as well as th G together with 5-bromocytosine could function as effectively as natural sgRNAs in an in vitro CRISPR-Cas9 cleavage assay. N 1 -Methylpseudouridine was also demonstrated to be a faithful non-canonical substitute of uridine to direct Cas9 nuclease cleavage when incorporated in sgRNA. The Cas9 inactivation by 7-deazapurines indicated the importance of the 7-nitrogen atom of purines in both sgRNA and PAM site for achieving efficient Cas9 cleavage. Additional aspects of this study are discussed in relation to the significance of sgRNA–protein and PAM–-protein interactions that were not highlighted by the Cas9–sgRNA–DNA complex crystal structure. These findings could expand the impact and therapeutic value of CRISPR-Cas9 and other RNA-based technologies. Nucleobase modifications enzymatically incorporated into the CRISPR-Cas9 system revealed the tolerance of Cas9 to m1Ψ- and fluorescent th G-modified sgRNA and requirements for PAM recognition. With the advent of CRISPR-Cas9 gene editing, we now have to hand a simple two-component system amendable to silencing and knock-in editing effectively any gene. Yet we must not forget that the implications of immunotoxicity along with the poor stability and specificity of canonical nucleic acids hold enormous challenges for in vivo applications, especially in gene therapy. Our study endorses the feasibility of the enzymatic approach to incorporate nucleobase modifications into the CRISPR-Cas9 system unveiling the tolerance of Cas9 to N 1 -methylpseudouridine (m1Ψ)- and emissive thienoguanosine ( th G)-modified sgRNA as well as thus far uncharted structural requirements for ensuring proper PAM recognition.

CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids

Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Structural basis of Cas9 DNA interrogation with a 5′ truncated sgRNA

Effect of the Phosphoryl Guanidine Modification in Chimeric DNA-RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro

Peptide Nucleic Acid-Mediated Regulation of CRISPR-Cas9 Specificity

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency

2′-O-methyl Modified Guide RNA Promotes the Single Nucleotide Polymorphism (SNP) Discrimination Ability of CRISPR–Cas12a Systems

Regulation of the CRISPR-Cas12a System by Methylation and Demethylation of Guide RNA.

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Partial DNA-guided Cas9 enables genome editing with reduced off-target activity

Structural insights into a high fidelity variant of SpCas9

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Spontaneous Embedding of DNA Mismatches Within the RNA:DNA Hybrid of CRISPR-Cas9

Innate programmable DNA binding by CRISPR-Cas12m effectors enable efficient base editing